<div id="readability-page-1"><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. </li><li> Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off </li></ul>The latest announcement is out from Adherium Ltd. ( (AU:ADR) ). Adherium Ltd. has announced the quotation of 15,000,000 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from December 4, 2025. This move is part of previously announced transactions and may enhance the company’s financial flexibility, potentially impacting its market position and providing opportunities for growth and development in the digital health sector. The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page. More about Adherium Ltd. Adherium Ltd. operates in the healthcare industry, focusing on developing digital health technologies. The company primarily offers solutions for monitoring and managing respiratory conditions, aiming to improve patient adherence and outcomes. Technical Sentiment Signal: Sell Current Market Cap: A$9.97M Find detailed analytics on ADR stock on TipRanks’ Stock Analysis page.</div>

Adherium Ltd. announced the quotation of 15 million fully paid ordinary securities on the ASX, effective December 4, 2025. This move aims to enhance financial flexibility and growth in the digital health sector. The latest analyst rating for AU:ADR stock is a Sell with a A$0.01 price target. Adherium Ltd. focuses on digital health technologies for respiratory conditions.

Adherium Ltd. Announces Quotation of New Securities on ASX